Targos Molecular Pathology GmbH

16/12/2021

Join our Team!

Current vacancies in Kassel, Germany:
Technical assistance / / (m/f/d)
Natural scientist / Bioinformatical Staff Scientist in Translational Research (m/f/d)
Board certified Pathologist (m/f/d)
Board certified Pathologist - Director of Pathology (m/f/d)

http://www.targos-gmbh.de/careers/

27/07/2021

Join our Team!

Current vacancies in Kassel, Germany:
- Technical assistance / / (m/f/d)
- Project Manager Associate (m/f/d)
- Project Manager (m/f/d)
- Board certified Pathologist (m/f/d)

http://www.targos-gmbh.de/careers/

08/06/2021

Targos Is Now a Discovery Life Sciences Company!
Targos’ capabilities are now available, alongside a full range of biospecimens and biomarker services offered by Discovery Life Sciences™ to help you discover, develop, and validate tissue biomarkers at every stage of research and development.

Power your precision biomarker programs with Targos-supported tissue biomarker services at Discovery Life Sciences.

Read more about Discovery’s Global Tissue Biomarker Services.

Click to read the press release.

Discovery expands capabilities with addition of leading European service provider to support tissue biomarker programs for research, clinical development and product launchHUNTSVILLE, Ala., May 18, 2021, Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, announced ...

18/05/2021

Discovery Life Sciences Acquires Targos To Create Market-Leading Global Tissue Biomarker Services

DISCOVERY EXPANDS CAPABILITIES WITH ADDITION OF LEADING EUROPEAN SERVICE PROVIDER TO SUPPORT TISSUE BIOMARKER PROGRAMS FOR RESEARCH, CLINICAL DEVELOPMENT, AND PRODUCT LAUNCH

http://www.targos-gmbh.de/press-release-may-18-2021/

14/04/2021

Agnostisches PD-L1 Training DACH Region

Die klinische Anwendung der Immuntherapie in der Onkologie hat sich in den letzten Jahren rasant entwickelt. Inzwischen sind eine Reihe verschiedener Medikamente, die an Immun-Checkpoint-Moleküle (PD-L1, PD-1, CTLA-4) binden, zusammen mit verschiedenen kommerziellen Assays zugelassen worden. Darüber hinaus werden in vielen Ländern auch einzelne Antikörper als sog. LDT (Lab Developed Test) eingesetzt. Daher ist die Wahl des diagnostischen Assays und des Scoring-Algorithmus komplex und kann je nach Indikation und geplantem therapeutischen Ansatz variieren. In der Ära der Präzisionsmedizin ist es wichtig hochwertige Schulungen für Pathologen anzubieten, um die Sicherheit bei der Interpretation und dem Scoring zu unterstützen, da diese eine direkte Auswirkung auf klinische Entscheidungen haben.

In Kooperation mit Diaceutics veranstaltet Targos virtuelle Gruppentraining in deutscher Sprache: 6. und 7. Mai 2021, 13-17 Uhr.

Anmeldung und detaillierte Informationen zu dieser Kollaboration finden Sie unter: https://www.dxrx.io/en/listing/teilnahme-an-einem-virtuellen-und-tumoragnostischen-pd-l1-training-deutschland-osterreich-schweiz-2101191005/show

22/03/2021

Unlocking the True Value of Multiplexing IHC – From Clinical Trial Programs Through to IVD Applications

Targos is thrilled to join the webinar entitled “Unlocking the True Value of Multiplexing IHC – From Clinical Trial Programs Through to IVD Applications”, hosted by ! The event takes place on March 30, with FREE attendance. We jointly will explore how multiplex immunofluorescence can move into clinical trials.

Check it out here:

Unlocking the True Value of Multiplexing IHC – From Clinical Trial Programs Through to IVD Applications Tuesday March 30, 2021 | 8am PST | 11am EST Webinar Hosted by Abcam VIEW AGENDA APPLY TO ATTEND The March Abcam Webinar will Cover: Welcome to the Abcam Webinar, an exclusive event providing lea...

22/03/2021

Targos is participating at the Biomarkers Insights Summit digital event on April 8th, 2021

Targos is thrilled to join the Biomarker Insights Summit, hosted by in partnership with CDx Engage! The event takes place on April 8, with FREE attendance, don’t miss out on joining biopharma, academic, CRO and diagnostic leaders as we look to connect the dots within the pathology and translational ecosystems. We jointly will explore how multiplex immunofluorescence, as an accessible, flexible and valuable tool, can improve validation of protein biomarkers in tissue when evaluating clinical utility of compounds of interest. Check it out here: https://ter.li/hqgdax

Oliver Stoss will be presenting at the upcoming Biomarker Insights Summit on April 8. Attendance is completely free! Don’t wait to sign up to join me as we explore opportunities for all to maximize the successes of biomarker-driven trials.

Register your free pass here: https://ter.li/hqgdax

Converting Biomarker Strategies into Actionable Insights for Effective Immunotherapies

28/01/2021

Press Release:

Cirdan and Targos strengthen their commitment to supporting pathologist professional development

Read more:
https://www.targos-gmbh.de/press-release-20210126/
https://www.cirdan.com/cirdan-and-targos-strengthen-their-commitment-to-supporting-pathologist-professional-development/

Cirdan, a global leader in pathology informatics and imaging, and Targos, a global leader in clinical biomarker services today announced that they have consolidated their commitment to advancing digital pathology education and the professional development of pathologists in a new collaboration agree...

18/01/2021

Annoucement:
Professional Expert Course Mikrosatelliteninstabilität und Mismatch Repair Defizienz (MMRD)

MSI Tutorial (Deutsch) –Virtuelles Training 09.03.2021


Weitere Informationen und Anmeldung:

Targos | A Leader in Biomarker Services

26/08/2020

Still open seats for virtual course PD-L1 Testing (SP142) by Dr J. Rueschoff.

There are still some open seats for our virtual course PD-L1 Testing (SP142) held by Dr Josef Rueschoff. The course main point will be about real stainings and discussions about edge cases. This course will be held in german.

We look forward to you.

Please sign up at:

Targos | A Leader in Biomarker Services

20/07/2020

PROFESSIONAL EXPERT COURSE
PD-L1 Testing (SP142) in tnBC

07.09.2020, Kassel
by Targos Advance

This course will be held in German language

For more information please see:
http://www.targos-gmbh.de/pd-l1-testing-sp142/

15/07/2020

Press release:
Diaceutics partners with Targos and HistoCyte Laboratories to drive global diagnostic testing standardization

Parsippany, NJ, July 14 2020 – Diaceutics PLC, (AIM: DXRX), today announces key partnerships on its DXRX platform, the world’s first diagnostic network for precision medicine, which will drive the global standardization of diagnostic testing. Targos Molecular Pathology and HistoCyte Laboratories...